Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kial-Ann M. Rasmussen, Breanna C. Stewart & William E. Janes. (2023) Feasibility of customized 3D-printed assistive technology within an existing multidisciplinary amyotrophic lateral sclerosis clinic. Disability and Rehabilitation: Assistive Technology 18:8, pages 1466-1472.
Read now
Read now
Joseph Boyle, David C. Wheeler, Ryan Naum, Paula Burke Brockenbrough, Michelle Gebhardt, LaVon Smith, Tremetris Harrell, Danielle Stewart & Kelly Gwathmey. (2023) Analysis of the spatial distribution of amyotrophic lateral sclerosis in Virginia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 669-677.
Read now
Read now
Roberto Teodoro Gurgel De Oliveira, Glauciane Costa Santana, Maria De Jesus Gonçalves, Guilherme Augusto De Freitas Fregonezi, Sancha Helena De Lima Vale, Lucia Leite-Lais & Mário Emílio Teixeira Dourado$suffix/text()$suffix/text(). (2023) A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to 2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 117-124.
Read now
Read now
Daniells Erazo, Jaime Luna, Pierre-Marie Preux, Marco Tulio Medina, Julien Magne, Farid Boumediene & Philippe Couratier. (2022) Amyotrophic lateral sclerosis mortality rates in Latin America and the Caribbean: a meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 608-619.
Read now
Read now
Paul Mehta, Jaime Raymond, Reshma Punjani, Theodore Larson, Moon Han, Frank Bove & D. Kevin Horton. (2022) Incidence of amyotrophic lateral sclerosis in the United States, 2014–2016. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 378-382.
Read now
Read now
Daniells Erazo, Jaime Luna, Pierre-Marie Preux, Farid Boumediene & Philippe Couratier. (2022) Epidemiological and genetic features of amyotrophic lateral sclerosis in Latin America and the Caribbean: a systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 4-15.
Read now
Read now
Jaime Luna, Pierre-Marie Preux, Giancarlo Logroscino, Daniells Erazo, Oscar H. Del Brutto, Farid Boumediene, Philippe Couratier & Benoit Marin. (2019) Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 404-412.
Read now
Read now
D. Kevin Horton, Shannon Graham, Reshma Punjani, Grete Wilt, Wendy Kaye, Kimberly Maginnis, Lauren Webb, Judy Richman, Richard Bedlack, Edward Tessaro & Paul Mehta. (2018) A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 126-133.
Read now
Read now
Koji Takei, Kikumi Tsuda, Fumihiro Takahashi, Manabu Hirai & Joseph Palumbo. (2017) An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 88-97.
Read now
Read now
Gary G. Schwartz & Marilyn G. Klug. (2016) Motor neuron disease mortality rates in U.S. states are associated with well water use. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 528-534.
Read now
Read now
Articles from other publishers (30)
Ikjae Lee, Hiroshi Mitsumoto, Seonjoo Lee, Edward Kasarskis, Michael Rosenbaum, Pam Factor‐Litvak & Jeri W. Nieves. (2023) Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis. Annals of Neurology.
Crossref
Crossref
Emily P. McCann, Natalie Grima, Jennifer A. Fifita, Sandrine Chan Moi Fat, Klaus Lehnert, Lyndal Henden, Ian P. Blair & Kelly L. Williams. (2023) Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants. Journal of Neuromuscular Diseases 10:6, pages 1127-1141.
Crossref
Crossref
Ingridy M. P. Barbalho, Aleika L. A. Fonseca, Felipe Fernandes, Jorge Henriques, Paulo Gil, Danilo Nagem, Raquel Lindquist, Thaisa Lima, João Paulo Queiroz dos Santos, Jailton Paiva, Antonio H. F. Morais, Mário E. T. Dourado Júnior & Ricardo A. M. Valentim. (2023) Digital health solution for monitoring and surveillance of Amyotrophic Lateral Sclerosis in Brazil. Frontiers in Public Health 11.
Crossref
Crossref
Betts Peters, Jack Wiedrick & Carolyn Baylor. (2023) Effects of Aided Communication on Communicative Participation for People With Amyotrophic Lateral Sclerosis. American Journal of Speech-Language Pathology 32:4, pages 1450-1465.
Crossref
Crossref
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar & Shahid Bashir. 2023. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
147
169
.
Srestha Mazumder, Matthew C. Kiernan, Glenda M. Halliday, Hannah C. Timmins & Colin J. Mahoney. (2022) The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review. Neuropathology and Applied Neurobiology 48:7.
Crossref
Crossref
Zachary Klock, Stephanie Dobak, Gail Houseman, Amy T. Cunningham & Margaret Kreher. (2021) Advance Care Planning and Healthcare Utilization in Patients With Amyotrophic Lateral Sclerosis: A Retrospective Chart Review. American Journal of Hospice and Palliative Medicine® 39:10, pages 1152-1156.
Crossref
Crossref
P. S. Goncharova, T. K. Davidova, N. A. Shnayder, M. A. Novitsky & R. F. Nasyrova. (2022) Epidemiology of Amyotrophic Lateral Sclerosis. Personalized Psychiatry and Neurology 2:1, pages 57-66.
Crossref
Crossref
Maysen Mesaros, Steven Lenz, Woobeen Lim, Jordan Brown, Luke Drury & Jennifer Roggenbuck. (2021) Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry. Genes 13:1, pages 76.
Crossref
Crossref
Nikita Moshkov, Aleksandr Smetanin & Tatiana V. Tatarinova. (2021)
Local ancestry prediction with
PyLAE
. PeerJ 9, pages e12502.
Crossref
Crossref
Daniel H. Daneshvar, Jesse Mez, Michael L. Alosco, Zachary H. Baucom, Ian Mahar, Christine M. Baugh, Jhaqueline P. Valle, Jennifer Weuve, Sabrina Paganoni, Robert C. Cantu, Ross D. Zafonte, Robert A. Stern, Thor D. Stein, Yorghos Tripodis, Christopher J. Nowinski & Ann C. McKee. (2021) Incidence of and Mortality From Amyotrophic Lateral Sclerosis in National Football League Athletes. JAMA Network Open 4:12, pages e2138801.
Crossref
Crossref
Marianna J. BledsoeLindsay Rechtman, Laurie WagnerPaul MehtaD. Kevin HortonWendy E. Kaye. (2021) Analysis of Biospecimen Demand and Utilization of Samples from the National Amyotrophic Lateral Sclerosis Biorepository. Biopreservation and Biobanking 19:5, pages 432-437.
Crossref
Crossref
Aleen D Saxton & Brian C Kraemer. (2021)
Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic
Caenorhabditis elegans
. G3 Genes|Genomes|Genetics 11:8.
Crossref
Crossref
Angeline S. Andrew, Erik P. Pioro, Meifang Li, Xun Shi, Jiang Gui, Elijah W. Stommel, Tanya H. Butt, Daniel Peipert, Patricia Henegan, Maeve Tischbein, Pamela Cazzolli, John Novak, Adam Quick, K. Doug Pugar, Komal Sawlani, Bashar Katirji, Todd A. Hayes, D. Kevin Horton, Paul Mehta & Walter G. Bradley. (2021) The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry. Neuroepidemiology 55:3, pages 196-205.
Crossref
Crossref
F. Henning, J. M. Heckmann, K. Naidu, L. Vlok, H. M. Cross & B. Marin. (2020) Incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4‐year prospective study. European Journal of Neurology 28:1, pages 81-89.
Crossref
Crossref
Benjamin Rix Brooks & Jerome E. Kurent. 2021. Public Policy in ALS/MND Care. Public Policy in ALS/MND Care
301
326
.
Lindsay Rechtman, Heather Jordan, Wendy Kaye, Maggie Ritsick & Paul Mehta. (2018) Increasing Patient Self-Enrollment in the National Amyotrophic Lateral Sclerosis Registry: Lessons Learned From a Direct to Provider Campaign. Journal of Patient Experience 7:1, pages 71-82.
Crossref
Crossref
Tanxin Liu, Dongchao Shen, Xunzhe Yang, Bo Cui, Hongfei Tai, Zhili Wang, Shuangwu Liu, Kang Zhang, Mingsheng Liu & Liying Cui. (2019) Early onset but long survival and other prognostic factors in Chinese sporadic amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 69, pages 74-80.
Crossref
Crossref
Kyo Yeon Jun, Jinseok Park, Ki-Wook Oh, Eun Mi Kim, Jong Seok Bae, Inah Kim & Seung Hyun Kim. (2019) Epidemiology of ALS in Korea using nationwide big data. Journal of Neurology, Neurosurgery & Psychiatry 90:4, pages 395-403.
Crossref
Crossref
Maisha T. Robinson & Danny Estupinan. 2019. Neuropalliative Care. Neuropalliative Care
101
115
.
Marieke Cornelia Johanna Dekker, Sarah Japhet Urasa, Marjolein Berendina Aerts & William P Howlett. (2018) Motor neuron disease in sub-Saharan Africa: case series from a Tanzanian referral hospital. Journal of Neurology, Neurosurgery & Psychiatry 89:12, pages 1349-1350.
Crossref
Crossref
Benoît Marin, Philippe Couratier, Annie Lannuzel & Giancarlo Logroscino. 2018. Neuroepidemiology in Tropical Health. Neuroepidemiology in Tropical Health
167
183
.
Michael A van Es, Orla Hardiman, Adriano Chio, Ammar Al-Chalabi, R Jeroen Pasterkamp, Jan H Veldink & Leonard H van den Berg. (2017) Amyotrophic lateral sclerosis. The Lancet 390:10107, pages 2084-2098.
Crossref
Crossref
J. Luna, G. Logroscino, P. Couratier & B. Marin. (2017) Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor. Revue Neurologique 173:5, pages 244-253.
Crossref
Crossref
S. Badal. 2017. Pharmacognosy. Pharmacognosy
337
361
.
Paul Mehta, Wendy Kaye, Leah Bryan, Theodore Larson, Timothy Copeland,, Jennifer Wu, Oleg Muravov & Kevin Horton. (2016) Prevalence of Amyotrophic Lateral Sclerosis — United States, 2012–2013. MMWR. Surveillance Summaries 65:8, pages 1-12.
Crossref
Crossref
Benoît Marin, Farid Boumédiene, Giancarlo Logroscino, Philippe Couratier, Marie-Claude Babron, Anne Louise Leutenegger, Massimilano Copetti, Pierre-Marie Preux & Ettore Beghi. (2016) Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. International Journal of Epidemiology, pages dyw061.
Crossref
Crossref
Jeffrey M. Statland, Richard J. Barohn, April L. McVey, Jonathan S. Katz & Mazen M. Dimachkie. (2015) Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 735-748.
Crossref
Crossref
Kevin A. Henry, Jerald Fagliano, Heather M. Jordan, Lindsay Rechtman & Wendy E. Kaye. (2015) Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009–2011. American Journal of Epidemiology 182:6, pages 512-519.
Crossref
Crossref
Heather Jordan, Jerald Fagliano, Lindsay Rechtman, Daniel Lefkowitz & Wendy Kaye. (2015) Effects of Demographic Factors on Survival Time after a Diagnosis of Amyotrophic Lateral Sclerosis. Neuroepidemiology 44:2, pages 114-120.
Crossref
Crossref